Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Laboratory Analytical Instruments

BioNano Genomics, Inc to acquire BioDiscovery

Announced Oct 12, 2021 · Closed Oct 19, 2021 · Private target

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock

Transaction

Acquirer
BioNano Genomics, Inc (BNGO)
Target
BioDiscovery
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Oct 19, 2021

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Not disclosed
To the target
Not disclosed

Classification

Sector
Healthcare
Buyer's industry
Laboratory Analytical Instruments
Sources
  • 8-K (EX-99.1) · Oct 12, 2021

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.